标题
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
作者
关键词
-
出版物
Brain Sciences
Volume 11, Issue 9, Pages 1211
出版商
MDPI AG
发表日期
2021-09-15
DOI
10.3390/brainsci11091211
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
- (2021) M. Galán-Ganga et al. Acta Neuropathologica Communications
- Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease
- (2020) Han Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
- (2020) Nurul Husna Ibrahim et al. Frontiers in Pharmacology
- Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq
- (2020) Fengjin Hao et al. LIFE SCIENCES
- Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
- (2020) R. Cooray et al. MOLECULAR NEUROBIOLOGY
- Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Aβ-induced neuronal toxicity
- (2020) Jingfu Zhao et al. NEUROSCIENCE LETTERS
- Chronic cannabidiol (CBD) treatment did not exhibit beneficial effects in 4-month-old male TAU58/2 transgenic mice
- (2020) Georgia Watt et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Emerging potential of cannabidiol in reversing proteinopathies
- (2020) Raju Dash et al. AGEING RESEARCH REVIEWS
- Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
- (2019) Jie Wu ACTA PHARMACOLOGICA SINICA
- Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis
- (2019) Mario Stampanoni Bassi et al. Frontiers in Neurology
- Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate
- (2019) Yang He et al. Nature Communications
- CB2 Cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP/PS1 mice
- (2019) Chao Li et al. NEUROSCIENCE LETTERS
- Potentiation of cannabinoid signaling in microglia by adenosine A 2A receptor antagonists
- (2019) Rafael Franco et al. GLIA
- The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25–35
- (2019) Aleidy Patricio-Martínez et al. NEUROSCIENCE
- Investigational BACE inhibitors for the treatment of Alzheimer’s disease
- (2019) Bruno P. Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise
- (2018) Christopher H. van Dyck BIOLOGICAL PSYCHIATRY
- Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
- (2018) Talarico Giuseppina et al. Current Neuropharmacology
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer’s Disease-Like Pathology
- (2018) Anne-Caroline Schmöle et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s disease
- (2018) Alicia López et al. Journal of Neuroinflammation
- Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
- (2018) Blathnaid Hughes et al. NEUROCHEMICAL RESEARCH
- NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies
- (2018) Caixia Zhang et al. Frontiers in Aging Neuroscience
- GSK3 and Tau: Two Convergence Points in Alzheimer's Disease
- (2018) Felix Hernandez et al. JOURNAL OF ALZHEIMERS DISEASE
- Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy
- (2018) Maria J. Casarejos et al. JOURNAL OF ALZHEIMERS DISEASE
- Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
- (2018) Iván Manuel et al. JOURNAL OF ALZHEIMERS DISEASE
- Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice
- (2018) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice
- (2018) David Cheng et al. JOURNAL OF ALZHEIMERS DISEASE
- Modeling amyloid beta and tau pathology in human cerebral organoids
- (2018) Cesar Gonzalez et al. MOLECULAR PSYCHIATRY
- Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain
- (2018) Danilo De Gregorio et al. PAIN
- NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice
- (2018) Michaela Kerstin Müller et al. Acta Neuropathologica Communications
- Endocannabinoid system in neurodegenerative disorders
- (2017) Balapal S. Basavarajappa et al. JOURNAL OF NEUROCHEMISTRY
- Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
- (2017) Aitana Sogorb-Esteve et al. MOLECULAR NEUROBIOLOGY
- The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
- (2017) Giulia Donvito et al. NEUROPSYCHOPHARMACOLOGY
- In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
- (2017) Georgia Watt et al. Frontiers in Pharmacology
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism
- (2016) Rosario Gajardo-Gómez et al. GLIA
- Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine
- (2016) Ester Aso et al. JOURNAL OF ALZHEIMERS DISEASE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Dysfunction of NMDA receptors in Alzheimer’s disease
- (2016) Yan Zhang et al. NEUROLOGICAL SCIENCES
- CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
- (2016) Ester Aso et al. Frontiers in Neuroscience
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons
- (2015) Steven Moore et al. Cell Reports
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- The γ-secretase complex: from structure to function
- (2014) Xian Zhang et al. Frontiers in Cellular Neuroscience
- Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
- (2013) Zhiyou Cai et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier
- (2013) Corbin Bachmeier et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
- (2013) Christoph Stumm et al. NEUROBIOLOGY OF AGING
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+Cells Through PPARγ Involvement
- (2013) Caterina Scuderi et al. PHYTOTHERAPY RESEARCH
- Aβ Secretion and Plaque Formation Depend on Autophagy
- (2013) Per Nilsson et al. Cell Reports
- Lack of Tau Proteins Rescues Neuronal Cell Death and Decreases Amyloidogenic Processing of APP in APP/PS1 Mice
- (2012) Karelle Leroy et al. AMERICAN JOURNAL OF PATHOLOGY
- Multiple Functions of Endocannabinoid Signaling in the Brain
- (2012) István Katona et al. Annual Review of Neuroscience
- The Endocannabinoid, Anandamide, Augments Notch-1 Signaling in Cultured Cortical Neurons Exposed to Amyloid-β and in the Cortex of Aged Rats
- (2012) Riffat Tanveer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients
- (2012) Maite Solas et al. NEUROBIOLOGY OF AGING
- Antioxidant Therapies for Alzheimer's Disease
- (2012) Ye Feng et al. Oxidative Medicine and Cellular Longevity
- The endocannabinoid system: a key modulator of emotions and cognition
- (2012) Patrizia Campolongo et al. Frontiers in Behavioral Neuroscience
- Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease
- (2011) Jan Mulder et al. BRAIN
- Single-channel Ca2+imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology
- (2011) Angelo Demuro et al. JOURNAL OF CELL BIOLOGY
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity
- (2011) Masoud Haghani et al. NEUROSCIENCE LETTERS
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Aβ Accelerates the Spatiotemporal Progression of Tau Pathology and Augments Tau Amyloidosis in an Alzheimer Mouse Model
- (2010) David E. Hurtado et al. AMERICAN JOURNAL OF PATHOLOGY
- Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
- (2010) I Magen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Wnt signal transduction pathway and apoptosis: a review
- (2010) Nives Pećina-Šlaus Cancer Cell International
- A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis
- (2010) Lin Teng et al. CELL RESEARCH
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
- (2010) Giles E. Hardingham et al. NATURE REVIEWS NEUROSCIENCE
- The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages
- (2009) Rosa María Tolón et al. BRAIN RESEARCH
- Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents
- (2009) Fumio Tsuji et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
- (2008) J. E. Lauckner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started